Ontario Supporting Groundbreaking Stem Cell Research
November 25, 2014 4:00 P.M.
The province is investing in the health of Ontarians by supporting stem cell researchers to develop new treatments and therapies to help those who live with debilitating and costly chronic diseases.
The establishment of the Ontario Institute for Regenerative Medicine (OIRM) will bring together world-class teams to conduct cutting-edge research and apply newly discovered treatments to a wide variety of diseases, including cancer, diabetes, blindness, heart and lung diseases.
The institute is a partnership between the Ontario Stem Cell Initiative (OSCI) and the Centre for Commercialization of Regenerative Medicine (CCRM). In addition to the breakthrough treatments that will improve the everyday lives of Ontarians, the institute will help the province commercialize new discoveries and benefit from significant economic opportunities in stem cell research.
Investing in research that supports the province's life sciences sector is part of the government's economic plan for Ontario. The four-part plan is building Ontario up by investing in people's talents and skills, building new public infrastructure like roads and transit, creating a dynamic, supportive environment where business thrives, and building a secure savings plan so everyone can afford to retire.
" Ontario is thrilled to support this collaborative initiative, which
holds the promise to help treat, manage and cure some of the world’s most
devastating diseases while offering significant economic benefits. Stem cells
were first discovered in Ontario and this new institute will help secure
Ontario’s leadership position in the critical field of regenerative
- Reza Moridi
Minister of Research and Innovation
" Ontario is an international leader in stem cell and regenerative
medicine research. This investment by the Government of Ontario ensures that we
maintain our leading-edge capacity and continue to build towards a healthier
future for Canadians."
- Janet Rossant
Interim Director of the Ontario Institute for Regenerative Medicine
" The government’s support of the Ontario Institute of Regenerative
Medicine will have a significant impact on our ability to commercialize
regenerative medicine products and technologies that will benefit Canadians
living with chronic and debilitating diseases. The launch of OIRM complements
CCRM's plan to build an international cell therapy manufacturing hub to
accommodate the discoveries stemming from Ontario's prolific research community
and accelerate treatments to the marketplace."
- Dr. Michael May
President and CEO, Centre for Commercialization of Regenerative Medicine
Terry Chemij Minister's Office
Brigitte Marleau Communications Branch